GATINEAU, Quebec, Oct. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp has wasted no time in reassuring its current medical patients that it has safeguarded products and bandwidth to continue to deliver the quality, award-winning Canadian medical cannabis products they have come to expect. Hydropothecary is HEXO Corp’s medical cannabis brand that offers innovative smoke-free alternatives.



“We recognize that the legalization of adult-use cannabis has led to many patients questioning whether licensed producers would shift their focus away from their medical clients. For Hydropothecary by HEXO Corp, that is not the case. Our work to produce and deliver products to our medical clients continues with fervor, as do our efforts to delivering innovation in our products and our service to our clients,” said Sebastien St-Louis, HEXO Corp’s Chief Executive Officer and co-founder. “We have secured inventory specifically for medical patients and we are proud to continue to earn their trust.”



Sold legally and directly in Canada to those with a medical document from a medical practitioner, Hydropothecary provides naturally grown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary patients have access to innovative products and first-rate customer service, starting with the registration process through to the 24/7 access to live, bilingual support.

Through partnerships like the one struck with the Gastrointestinal Society, HEXO Corp also works to transfer knowledge to patients organizations on the benefits and risks of medical cannabis.

About HEXO Corp.

HEXO Corp. creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with over 310,000 sq. ft. of production capacity with construction on another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.



Investor Relations:

Kathy Chow

1-866-438-8429

invest@HEXO.com

www.ir.hexo.com

Media Relations:

Sarah Brown

media@hexo.com

Director

Adam Miron

819-639-5498